Effects of Ketamine on Postoperative Pain After Remifentanil-Based Anesthesia for Major and Minor Surgery in Adults: A Systematic Review and Meta-Analysis
Metadatos
Mostrar el registro completo del ítemAutor
García Henares, Juan; Moral Muñoz, José Antonio; Salazar, Alejandro; Pozo Gavilán, Esperanza DelEditorial
Frontiers Media
Materia
Remifentanil Ketamine Minor surgery Mayor surgery NMDA antagonist Meta-analysis
Fecha
2018-08-17Referencia bibliográfica
García-Henares JF, Moral-Munoz JA, Salazar A and Del Pozo E (2018) Effects of Ketamine on Postoperative Pain After Remifentanil-Based Anesthesia for Major and Minor Surgery in Adults: A Systematic Review and Meta-Analysis. Front. Pharmacol. 9:921.
Resumen
Ketamine, an N-methyl-D-aspartate (NMDA) receptor antagonist, has been postulated
as an adjuvant analgesic for preventing remifentanil-induced hyperalgesia after surgery.
This systematic review and meta-analysis aims to assess the effectiveness of ketamine
[racemic mixture and S-(+)-ketamine] in reducing morphine consumption and pain
intensity scores after remifentanil-based general anesthesia. We performed a literature
search of the PubMed, Web of Science, Scopus, Cochrane, and EMBASE databases
in June 2017 and selected randomized controlled trials using predefined inclusion and
exclusion criteria. To minimize confounding and heterogeneity, studies of NMDA receptor
antagonists other than ketamine were excluded and the selected studies were grouped
into those assessing minor or major surgery. Methodological quality was evaluated
with the PEDro and JADA scales. The data were extracted and meta-analyses were
performed where possible. Twelve RCTs involving 156 adults who underwent minor
surgery and 413 adults who underwentmajor surgery were included in themeta-analysis.
When used as an adjuvant to morphine, ketamine reduced postoperative morphine
consumption in the first 24 h and postoperative pain intensity in the first 2 h in the minor
and major surgery groups. It was also associated with significantly reduced pain intensity
in the first 24 h in the minor surgery group. Time to the first rescue analgesia was longer in
patients who received ketamine and underwent major surgery. No significant differences
in the incidence of ketamine-related adverse effects were observed among patients in
the intervention group and controls. This systematic review and meta-analysis show that
low-dose (<0.5 mg/kg for iv bolus or <5 μg/kg/min for iv perfusion) of ketamine reduces
postoperative morphine consumption and pain intensity without increasing the incidence
of adverse effects.